API’s Post

Two weeks ago, DIGITIMES Asia featured our portfolio company Simmunome Inc.! The article covers in detail Simmunome Inc.’s origin story and highlight how they identify as a techbio company - focused on using technology to analyze biological data - rather than a biotech company directly developing therapeutics. It also touches on their global expansion plan, seeing Asia as a great starting ground for international clinical validations, to ultimately democratize #AI within medicine worldwide. Dive into the conversation at the link here: https://bit.ly/4eSEtmq #BKRCapital #BKRPortco #VentureCapital #BlackFounders #BlackEntrepreneurs #BlackInTech #TechStartups #Innovation #Growth

Biotech IPO Trend During and Post Pandemic In the rapidly involving field of biomedical science, researchers and clinicians spent tremendous effort discovering novel components, revealing new cures, and generating up-to-date medications that can benefit the public. Like all startups, one of the most important processes for biomedical entrepreneurs is IPO. This blog will make a brief introduction to biomedical IPO trends based on data from the last four years. https://lnkd.in/gvkbbkvM #innovation #biotech #IPOTrend

#Startups : The Life Sciences Tech has over 6.47K+ startups that comprise of companies which provide digital solutions to life sciences industry, including #Pharma , medical devices, diagnostics and life sciences instruments & reagents. It also includes internet-first platforms for recruitment of patients, KOLs, and sites for clinical trials as well as marketplaces to procure materials for clinical trials among others. Life Sciences Tech sector is one of the most active sectors for investors with an overall funding of USD 49.2B in 2.1K+ companies. It is also interesting to note that more than half of the funding has been raised in the last 3 years (2021-2023). https://lnkd.in/gvtkkM7s

The countdown is truly on to another innovation bonanza at UMassM2D2 next Wednesday! ⏰ With the biggest #IMPACT Cohort ever comes nearly double the networking and learning opportunities. You can connect with all the group and learn which 8 have been selected for the live pitch-off. 🎤 From natural sunscreen to deep brain stimulation, this group has you covered from head to toe with novel technologies. 👩⚕️ Hope you can join us again to support the next wave of leading founders. 🚀 #Medtech #Startups #KeepInnovating

STARTUP -TRACKER: Neuranics, a healthcare diagnostics startup, has successfully raised $700K USD funding in a seed round led by Inflection Point Ventures (IPV). Click to read: https://lnkd.in/ge3_7dck #seedfunding #funds #startup #diagnostics #healthtech #biovoicenews

🚀 Discovering cutting-edge BioTech solutions? Remember, success isn't just about the idea; it's about infrastructure too! NewVale is investing in the foundations that power drug startups, ensuring the path to innovative treatments is as efficient as the science behind them. 🧪 From tailored machine learning software to essential manufacturing services, NewVale backs the unsung heroes of pharma services. For my executive network in MedTech, HealthTech, BioTech and pharma: Keep an eye out for the next step in optimizing the journey from lab to patient! Your next partnership could be with a firm that's strengthening the very backbone of our industry. #Biotech #PharmaInfrastructure #InnovationInvestment

Empowering Life Sciences Innovation at Enlil 🌱 At Enlil, we are shaping the future of life sciences by empowering startups in regulated sectors like biotech, pharma, and medtech. Through the Shifamed hub, powered by Enlil, we provide specialized lab spaces, prototype-to-low-volume production manufacturing, expert mentorship, and regulatory guidance to help our portfolio companies tackle complex challenges and accelerate their time-to-market. With access to funding and a collaborative ecosystem, we're enabling the next wave of transformative healthcare solutions that will redefine the future of medicine. #LifeSciences #Innovation #Biotech #Healthcare #Startups #RegulatoryCompliance #Enlil #MedTech

Global Digital Therapeutics (DTx) Startup Ecosystem: Deep Dive Analysis Through an extensive search and review of publicly available information, 172 startups were selected for detailed analysis based on specific criteria: Business Profile, Product, Technological Innovation including Patents, Investment and Fund Raising, Key Leadership, Revenue, Market, Clinical Trials, and Reimbursement Contents Global DTx Startup Landscape 1.5Q 2024 Global DTx Startups' Key Target Health Conditions 1.5Q 2024  Global DTx Product Landscape 1.5Q 2024  Global DTx Innovation (Patent) Landscape 1.5Q 2024 Partnerships between DTx Startups and Pharmaceuticals & Clinics 1.5Q 2024 Global DTx Startup Fund Raising Cases 1.5Q 2024 Conundrum in DTx Ecosystem Future of Global DTx Ecosystem Analysis Samples Expert invitation for comment: Koen Kas Tony J Simon, Ph.D. Kelly Stein-Marcus Marguerite Manteau-Rao, LCSW, MBA Janvi Parmar Ravi Janapureddy Howard Berman, PhD Seth Feuerstein Torsten Schröder, MD, PhD Logan Harper Stephen Hamm, MBA Bikram Gangwar Michaël Cardinal Sean G.(Sungjee) Kang, MD, MPH Robert A. Renata Redondo Bonaldi, PhD, Global MBA Ian Miller Jon Redmond Joshua Bull Klaudia Dobrev Marcelo Duhalde #digitaltherapeutics #dtx #startup #product #innovation #patent #fundraising #ecosystem 

🚀At Cytocast, we are driving the future of drug development with our Simulated Cell and Digital Twin technologies. Backed by investors like Creative Accelerator, a Hungary-based incubator with a strong focus on biotech and medtech startups, we’ve been able to turn bold ideas into reality. Their support and expertise help us push the boundaries of computational biology and personalized medicine. ❗We invite visionary investors to join us in creating the next wave of breakthroughs. 🔗 Learn more about investing in Cytocast: https://lnkd.in/dcU7uhtc #biotech #drugdiscovery #healthtech #precisionmedicine #investing